FilingReader Intelligence
Marksans Pharma reports 17% revenue growth in Q1
August 13, 2025 at 06:09 AM UTC•By FilingReader AI
Marksans Pharma reported revenue from operations of ₹453.16 crore for the quarter ended June 30, 2025, up from ₹386.95 crore in the same period last year.
Profit before tax rose to ₹71.15 crore from ₹59.85 crore, while profit after tax increased to ₹57.87 crore from ₹47.96 crore. Diluted earnings per share improved to ₹1.28 from ₹1.07 previously.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:MARKSANS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Marksans Pharma publishes news
Free account required • Unsubscribe anytime